Zobrazeno 1 - 10
of 140
pro vyhledávání: '"S. Karatapanis"'
Autor:
Alexandra Kourakli, Antonis Kattamis, Barbara Toli, Kalliopi Zachou, Ioannis Goulis, John Koskinas, George V. Papatheodoridis, S. Karatapanis, Foteini Petropoulou, Emmanouil Sinakos, Themistoklis Vassiliadis, George N. Dalekos, Dimitrios Kountouras, Maria Tampaki, Pinelopi Arvaniti, Konstantinos Maragkos, Evangelos Akriviadis, Aristea Bellou, Efthymia Vlachaki, Georgios I. Tsiaoussis, Christos Triantos
Publikováno v:
British Journal of Haematology. 178:130-136
Summary Interferon-based regimens for chronic hepatitis C (CHC) were often deferred in patients with β-thalasaemia major (β-TM) due to poor efficacy and tolerance. Current guidelines recommend direct-acting antivirals (DAAs) for these patients. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234a9882aea855072e5c6b46cbe9dc95
https://doi.org/10.1111/bjh.14640
https://doi.org/10.1111/bjh.14640
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G, Vourli, G, Papatheodoridis, M, Raptopoulou, G N, Dalekos, A, Hounta, G, Nikolopoulou, I, Zouboulis-Vafeiadis, E, Manesis, G, Kitis, C, Gogos, I, Ketikoglou, G, Hatzis, T, Vasilialdis, S, Karatapanis, K, Mimidis, C, Drakoulis, G, Touloumi, The Hepnet-Greece
Publikováno v:
Hippokratia. 20(3)
Although effective treatment in terms of inducing virological and biochemical response for chronic hepatitis B (CHB) is available, its effect on the clinical course of the disease has not yet been accurately estimated. Objective of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f01669114feeef9c1caab3849b3eb91
https://pubmed.ncbi.nlm.nih.gov/29097888
https://pubmed.ncbi.nlm.nih.gov/29097888
Autor:
Spilios Manolakopoulos, J. Elefsiniotis, M. Economou, Giota Touloumi, S. Bethanis, G Sourvinos, Demetrios A. Spandidos, Jiannis Vlachogiannakos, Christos Triantos, Alec Avgerinos, Dimitrios Tzourmakliotis, S. Karatapanis
Publikováno v:
Alimentary Pharmacology and Therapeutics. 23:787-795
Summary Background Factors that predict response and breakthrough phenomenon to lamivudine monotherapy in patients with HBeAg-negative chronic hepatitis B have not been well defined. Aim To determine pre-treatment and on treatment variables that pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acd034116579a7d081775ed03df4ea9d
https://doi.org/10.1111/j.1365-2036.2006.02806.x
https://doi.org/10.1111/j.1365-2036.2006.02806.x
Autor:
I. Ketikoglou, Ioannis S. Elefsiniotis, Christos Triantos, Maria Tampaki, Theofanie Karaoulani, Theodoros Voulgaris, Argyro Koukoufiki, Emanuel K. Manesis, Maria-Vasiliki Papageorgiou, Evangelos Cholongitas, John Goulis, Georgios Ntetskas, Dimitrios Karagiannakis, John Koskinas, Emanuel Sinakos, George N. Dalekos, Maria Schina, Evangelos Akriviadis, Andreas Kapatais, Spilios Manolakopoulos, Anastasia Kourikou, John Vlachogiannakos, Chrisostomos Tsolias, S. Karatapanis, George V. Papatheodoridis, Melanie Deutsch, Panagiota Ioannidou, Vassilios A. Sevastianos, Eftychia Evangelidou, Nikolaos K. Gatselis
Publikováno v:
Gastroenterology. 152:S1093
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a00dbd3e397703ec1efb44d12d8bdf9
https://doi.org/10.1016/s0016-5085(17)33683-1
https://doi.org/10.1016/s0016-5085(17)33683-1
Autor:
Spilios Manolakopoulos, Emmanouil Sinakos, Jiannis Vlachogiannakos, T Voulgaris, John Koskinas, Georgios N. Dalekos, Panagiota Ioannidou, Evangelos Cholongitas, Vassilios A. Sevastianos, Maria-Vasiliki Papageorgiou, John Goulis, S. Karatapanis, E. Akriviadis, Eftychia Evangelidou, George V. Papatheodoridis, T. Karaoulani, Nikolaos K. Gatselis, Melanie Deutsch, Maria Schina, Maria Tampaki, Anastasia Kourikou, Argyro Koukoufiki, Christos Triantos, E.K. Manesis, Dimitrios Karagiannakis, I. Ketikoglou, Ioannis S. Elefsiniotis, Georgios Ntetskas, A. Kapatais, Chrisostomos Tsolias
Publikováno v:
Journal of Hepatology. 66:S502
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c0978e178f4451853744df3abce8f7a
https://doi.org/10.1016/s0168-8278(17)31403-4
https://doi.org/10.1016/s0168-8278(17)31403-4
Autor:
O, Anagnostou, S, Manolakopoulos, G, Bakoyannis, G, Papatheodoridis, A, Zisouli, M, Raptopoulou-Gigi, E, Manesis, I, Ketikoglou, G, Dalekos, C, Gogos, T, Vassiliadis, D, Tzourmakliotis, S, Karatapanis, S, Kanatakis, Zoumpoulis, A, Hounta, S, Koutsounas, G, Giannoulis, N, Tassopoulos, G, Touloumi
Publikováno v:
Hippokratia. 18(1)
Patients with genotype 4 (G4) chronic hepatitis C (CHC) are considered a difficult to treat population, although current data on G4 treatment responsiveness and duration are controversial. Greece represents a country with an intermediate prevalence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8e5396969494668b7f2863cae3144a5f
https://pubmed.ncbi.nlm.nih.gov/25125954
https://pubmed.ncbi.nlm.nih.gov/25125954
Autor:
George N. Dalekos, Christos Triantos, Konstantinos Mimidis, Christos Drakoulis, Ioannis Goulis, Evangelos Akriviadis, S. Karatapanis, George Germanidis, Maria Raptopoulou-Gigi, Georgios Bakalos, Elias Zintzaras, Melanie Deutsch, George V. Papatheodoridis
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 35(5)
Background & Aims We assessed predictors of response in HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2a in routine clinical practice. Methods Ninety-five HBeAg-negative patients received peginterferonalfa-2a for 48 week
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d606ce609a0b75cbfbfc7d9770dfbfaa
https://pubmed.ncbi.nlm.nih.gov/25368957
https://pubmed.ncbi.nlm.nih.gov/25368957
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
V, Papastergiou, E A, Tsochatzis, M, Rodriguez-Peralvarez, M, Rodriquez-Peralvarez, E, Thalassinos, G, Pieri, P, Manousou, G, Germani, C, Rigamonti, V, Arvaniti, S, Karatapanis, A K, Burroughs
Publikováno v:
Alimentary pharmacologytherapeutics. 38(11-12)
In primary biliary cirrhosis (PBC), biochemical criteria at 1 year are considered surrogates of response to ursodeoxycholic acid (UDCA). However, due to the slow natural history of PBC, evaluation at 1 year may be suboptimal to assess the therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b4a891405d73ead36f3d65b0539d9d
https://pubmed.ncbi.nlm.nih.gov/24330248
https://pubmed.ncbi.nlm.nih.gov/24330248